NXGL NexGel Inc

NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will participate at the Dawson James Securities 7th Annual Small Cap Growth Conference in Jupiter, Florida and the LD Micro Main Event XV Conference in Los Angeles, California in October 2022.

Dawson James Securities 7th Annual Small Cap Growth Conference Date: Wednesday, October 12th, 2022Time: Wednesday, October 12th at 5:00 P.M. ETLocation: Wyndham Grand Hotel at Jupiter, FloridaTo attend, please contact your Dawson James representative.

LD Micro Main Event XV Date: Tuesday, October 25th – Wednesday, October 27th, 2022Time: Wednesday, October 26th at 8:30 A.M. PT Location: Luxe Sunset Boulevard Hotel at Los Angeles, CaliforniaTo attend, register here.

If you would like to book 1x1 investor meetings with NEXGEL, please contact your Dawson James representative, LD Micro representative or send an email to NEXGEL@kcsa.com.

About NEXGEL, INC.

NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

Investor Contacts:Valter Pinto, Managing DirectorKCSA Strategic Communications212.896.1254valter@kcsa.com

Media Contacts:Raquel ConaKCSA Strategic Communications212.896.1204rcona@kcsa.com